Background illustration for clinical trials search

Paid Clinical Trials Oklahoma City

Discover 572 paid clinical trials in Oklahoma City, Oklahoma. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer

for
Hematopoietic and Lymphatic System Neoplasm,
Location: Oklahoma City OK, Fort Smith AR, Dallas TX,
Sponsor: Children's Oncology Group

Sex: Female

Age: 0 - 39

Code: NCT06513962

Phase 3, Recruiting

Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors

for
Metastatic Malignant Neoplasm in the Liver,
Location: Oklahoma City OK, Fort Smith AR, Joplin MO,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT05040360

Phase 2, Recruiting

Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)

for
Malignant Female Reproductive System Neoplasm,
Location: Oklahoma City OK, Richardson TX, Dallas TX,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06126276

Phase 2, Recruiting

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

for
Acute Leukemia of Ambiguous Lineage,
Location: Oklahoma City OK, Dallas TX, Fort Worth TX,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0 - 1

Code: NCT06317662

Phase 2, Recruiting

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

for
Bladder Adenocarcinoma, Bladder Clear Cell Adenocarcinoma,
Location: Oklahoma City OK, Lawton OK, Richardson TX,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT03866382

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

for
Clear Cell Renal Cell Carcinoma, Renal Cell Carcinoma (RCC),
Location: Oklahoma City OK, Lawton OK, Richardson TX, Dallas TX,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT06661720

Phase 3, Recruiting

Letrozole in Uterine Leiomyosarcoma

for
Uterine Leiomyosarcoma
Location: Oklahoma City OK, Shreveport LA, Aurora CO,
Sponsor: GOG Foundation

Sex: Female

Age: 18+

Code: NCT05649956

Phase 2, Recruiting

FT825/ONO-8250, an Off-the-Shelf, HER2 CAR-T, With or Without Monoclonal Antibodies in Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Oklahoma City OK, Houston TX, St Louis MO, Nashville TN,
Sponsor: Fate Therapeutics

Sex: All

Age: 18+

Code: NCT06241456

Phase 1, Recruiting

A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer

for
Endometrial Cancer
Location: Oklahoma City OK
Sponsor: Alliance Foundation Trials, LLC.

Sex: Female

Age: 18+

Code: NCT04486352

Phase 1, Phase 2, Recruiting

CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.

for
Epithelial Ovarian Cancer, Primary Peritoneal,
Location: Oklahoma City OK, Fort Worth TX, St Louis MO,
Sponsor: TORL Biotherapeutics, LLC

Sex: Female

Age: 18+

Code: NCT06690775

Phase 2, Recruiting

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

for
Acute Myeloid Leukemia, Mixed Lineage Leukemia Gene Mutation,
Location: Oklahoma City OK, Dallas TX, Fairway KS, Austin TX,
Sponsor: Kura Oncology, Inc.

Sex: All

Age: 18+

Code: NCT05735184

Phase 1, Recruiting

A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors

for
Triple Negative Breast Cancer, Breast Cancer,
Location: Oklahoma City OK, Dallas TX, Houston TX, Sioux Falls SD,
Sponsor: Day One Biopharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT05377996

Phase 1, Phase 2, Recruiting

Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer

for
Endometrial Cancer, Endometrioid Tumor, Cancer, Tumor,
Location: Oklahoma City OK, Tyler TX, Little Rock AR,
Sponsor: Aadi Bioscience, Inc.

Sex: All

Age: 18+

Code: NCT05997017

Phase 2, Recruiting

Safety and Efficacy of OT-82 in Participants With Relapsed or Refractory Lymphoma

for
Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell,
Location: Oklahoma City OK, Birmingham AL, Ann Arbor MI,
Sponsor: Oncotartis, Inc.

Sex: All

Age: 18+

Code: NCT03921879

Phase 1, Recruiting

A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors

for
Ovarian Cancer, Solid Tumor
Location: Oklahoma City OK, San Antonio TX, Houston TX, Denver CO,
Sponsor: OnCusp Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06234423

Phase 1, Recruiting

A Phase 2 Study of Avutometinib (VS-6766) Plus Defactinib

for
Endometrioid Cancer, Mucinous Ovarian Cancer,
Location: Oklahoma City OK, Albuquerque NM, New Orleans LA,
Sponsor: University of Oklahoma

Sex: Female

Age: 18 - 70+

Code: NCT05512208

Phase 2, Recruiting

Phase 1/2 Study of PYX-201 in Combination With Pembrolizumab in Advanced Solid Tumors

for
Advanced Solid Tumors
Location: Oklahoma City OK, Houston TX, Chicago IL, Pittsburgh PA,
Sponsor: Pyxis Oncology, Inc

Sex: All

Age: 18+

Code: NCT06795412

Phase 1, Phase 2, Recruiting

Relugolix + Enzalutamide Study in High-Risk Prostate Cancer

for
Androgen Deprivation Therapy, Locally Advanced Prostate Cancer
Location: Oklahoma City OK
Sponsor: University of Oklahoma

Sex: Male

Age: 18+

Code: NCT06130995

Phase 1, Recruiting

A First-in-Human Study of SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors

for
Solid Tumor, Breast Cancer, Pancreatic Cancer, Ovarian Cancer,
Location: Oklahoma City OK, Houston TX, Gilbert AZ, Detroit MI,
Sponsor: Qurgen Inc.

Sex: All

Age: 18+

Code: NCT05989724

Phase 1, Recruiting

JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC

for
Carcinoma, Squamous Cell
Location: Oklahoma City OK, Birmingham AL, Lexington KY,
Sponsor: Johnson & Johnson Enterprise Innovation Inc.

Sex: All

Age: 60+

Code: NCT04892173

Phase 3, Recruiting